StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a report published on Friday. The firm issued a buy rating on the stock.
Mannatech Price Performance
MTEX stock opened at $11.87 on Friday. The stock has a market capitalization of $22.37 million, a price-to-earnings ratio of -14.65 and a beta of 1.18. The firm’s 50-day moving average price is $8.98 and its two-hundred day moving average price is $7.94. The company has a current ratio of 1.25, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44. Mannatech has a 12-month low of $6.75 and a 12-month high of $13.00.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. The business had revenue of $31.73 million for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Further Reading
- Five stocks we like better than Mannatech
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- 3 REITs to Buy and Hold for the Long Term
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- What is the FTSE 100 index?
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.